Format

Send to

Choose Destination
Sci Rep. 2017 Apr 19;7(1):957. doi: 10.1038/s41598-017-01109-4.

Ketogenic diet attenuates hepatopathy in mouse model of respiratory chain complex III deficiency caused by a Bcs1l mutation.

Author information

1
Folkhälsan Research Center, Helsinki, Finland.
2
Faculty of Medicine, University of Helsinki, Helsinki, Finland.
3
Division of Infection Medicine, Clinical Sciences, Lund University, Lund, Sweden.
4
Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
5
Competence Centre on Health Technologies, Tartu, Estonia.
6
Molecular Neurology Research Program, University of Helsinki, Helsinki, Finland.
7
Metabolomics Unit, Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland.
8
Department of Genetics and Molecular Medicine, King's College London, England, UK.
9
National Institute for Health and Welfare, Helsinki, Finland.
10
Department of Clinical Sciences, Lund, Pediatrics, Lund University, Lund, Sweden.
11
Children's Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
12
Folkhälsan Research Center, Helsinki, Finland. jukka.kallijarvi@helsinki.fi.

Abstract

Mitochondrial disorders are among the most prevalent inborn errors of metabolism but largely lack treatments and have poor outcomes. High-fat, low-carbohydrate ketogenic diets (KDs) have shown beneficial effects in mouse models of mitochondrial myopathies, with induction of mitochondrial biogenesis as the suggested main mechanism. We fed KD to mice with respiratory chain complex III (CIII) deficiency and progressive hepatopathy due to mutated BCS1L, a CIII assembly factor. The mutant mice became persistently ketotic and tolerated the KD for up to 11 weeks. Liver disease progression was attenuated by KD as shown by delayed fibrosis, reduced cell death, inhibition of hepatic progenitor cell response and stellate cell activation, and normalization of liver enzyme activities. Despite no clear signs of increased mitochondrial biogenesis in the liver, CIII assembly and activity were improved and mitochondrial morphology in hepatocytes normalized. Induction of hepatic glutathione transferase genes and elevated total glutathione level were normalized by KD. Histological findings and transcriptome changes indicated modulation of liver macrophage populations by the mutation and the diet. These results reveal a striking beneficial hepatic response to KD in mice with mitochondrial hepatopathy and warrant further investigations of dietary modification in the management of these conditions in patients.

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center